|
Lazaro Sanchez AD, Benitez Fuentes JD, Gil GL, Garcia MTG, Moreno EF, Zamora PC, Yago JB, Mohamed KM, Arroyo Rodriguez AB. Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report. J Clin Med. 2025 Feb 17;14(4):1333. doi: 10.3390/jcm14041333. PubMed PMID: 40004863; PubMed Central PMCID: PMC11856639.
AÑO: 2025; IF: 2.9
|
40004863
|
Sanchez-Espinosa A, Garcia-Rodriguez J, Alonso-Aguirre V, Acosta-Ortega JM, Conesa-Zamora P, Garcia-Solano J, Luengo-Gil G. Expression of Fascin and DNA Topoisomerase 2-Alpha in Breast Carcinoma: Correlation with Histological Subtypes and Other Prognostic Markers. Int J Mol Sci. 2025 Mar 27;26(7):3076. doi: 10.3390/ijms26073076. PubMed PMID: 40243780; PubMed Central PMCID: PMC11988776.
AÑO: 2025; IF: 4.9
|
|
Rodriguez-Martinez A, Giraldo-Ruiz L, Ramos MC, Luque I, Ribeiro D, Postigo-Corrales F, Alburquerque-Gonzalez B, Montoro-Garcia S, Arroyo-Rodriguez AB, Conesa-Zamora P, Hurtado AM, Luengo-Gil G, Perez-Sanchez H. Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer. Sci Rep. 2025 Apr 28;15(1):14906. doi: 10.1038/s41598-025-96457-x. PubMed PMID: 40295602; PubMed Central PMCID: PMC12037858.
AÑO: 2025; IF: 3.9
|
|
Muniz-Castrillo M, Blaya Boluda N, Garcia-Torralba E, Jimenez-Fonseca P, Gonzalez Del Rey C, Balbin M, Luengo-Gil G, Ayala de la Pena F, Esteban Gonzalez E, Carmona-Bayonas A. Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clin Transl Oncol. 2025 May 4. doi: 10.1007/s12094-025-03933-x. Online ahead of print. PubMed PMID: 40319412.
AÑO: 2025; IF: 2.5
|
|
Morva A, Arroyo AB, Andreeva L, Tapia-Abellan A, Luengo-Gil G. Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review. Front Immunol. 2025 Jun 12;16:1615760. doi: 10.3389/fimmu.2025.1615760. eCollection 2025. PubMed PMID: 40574837; PubMed Central PMCID: PMC12198237.
AÑO: 2025; IF: 5.9
|